Benignity or malignancy of cancer

The benignity or malignancy of a cancer in fact depends on the capability of tissular reaction of a specific organ expressing itself ultimately in the ability to encyst fungal cells, and to prevent them from developing in ever-larger colonies. This can be achieved more easily where the ratio between differentiated cells and connective tissue is in favour of the former.
Situated between the impervious noble tissues, then, and the defenceless connective, the differentiated connective structures (the glandular structures in particular) represent that medium term which is only somewhat vulnerable to attack, because of an ability to offer a certain type of defence.

And it is in these conditions that benign tumours are formed, that is, where the glandular connective tissue is successful in forming hypertrophic and hyperplastic cellular embankments against the parasites.

In the stomach and in the lung, instead, since there are no specific glandular units, the target organ, provided with a small defensive capability, is at the mercy of the invader. Furthermore, it is worth mentioning how several types of intimate fungal invasion do not determine the appearance of malignant or benign tumours, but a type of particular benign tumour (specific degenerative alterations) as is the case of some organs or apparatuses that do not have peculiar glandular structures, but nevertheless are attacked in their connective tissue, but in a limited way.

Tumour = fungus

If we consider, in fact, multiple sclerosis, SLA, psoriasis, nodular panartherite, etc. the possible development of the fungus in a three-dimensional sense is actually limited by the anatomic configuration of the invaded tissues, so that only a longitudinal expansion is allowed.
Going back to the precondition of a-reactivity that is necessary for neoplastic development in a specific individual, it is permissible to affirm how in the human body each external or internal element that determines a reduction of well-being in an organism, organ or tissue, possesses oncogenic potentiality. This is not so much because of an intrinsic damaging capability as much as for a generic property of favouring the fungal (that is, tumoral) flourishing.
Then the causal network so much invoked in contemporary oncology, which involves toxic, genetic, immunological, psychological, geographical, moral, social, and other factors, finds a correct classification only in a mycotic infectious perspective where the arithmetical and diachronic summation of harmful elements works as a cofactor to the external aggression.
Having theoretically demonstrated the equivalency tumour = fungus, it is clear how this interpretative key offers a long series of questions concerning the contemporary therapies both oncological (used without reference indexes) and antimycotic (utilised only at a superficial level).
Which path is best to walk today, then, when faced with a cancer patient, since the conventional oncological treatment, not being etiological, can only occasionally have positive effects and most of the time produces damage?

Almost exclusively negative effects

In the fungal perspective in fact, the effectiveness of surgery is noticeably reduced because of the extreme diffusibility and invasiveness characteristic of a mycelial conglomerate. Surgery’s to solve the problem is therefore tied to the case — to conditions, that is, in which one has the luck to completely remove the entire colony (which is often possible in the presence of a sufficient encystment; but here we are in the case of benign tumours).
Chemotherapy and radiotherapy produce almost exclusively negative effects, both for their specific ineffectiveness, and for their high toxicity and harmfulness to the tissues, which in the last analysis favours mycotic aggressiveness.
By contrast, an anti-fungal, anti-tumour specific therapy would keep into account the importance of the connective tissue, together with the reproductive complexity of fungi. Only by attacking the fungi across the spectrum of all its forms, at points where it is most vulnerable from the nutritional point of view, would it be possible to hope to eradicate them from the human organism.

Examples of the treatment with sodium bicarbonate

Brain cancer

All brain tumors both primary and metastatic in general regress or stop growing after therapy with sodium bicarbonate at five per cent solution. The therapy must be performed for at least six to eight days for the first cycle because the disease starts again in a relatively short time and often becomes irreversible if the period is less than six days.

The administration of the solutions takes place through sequential catheterization of the two internal carotids and of the Willis’ Circle with 150 cm3 in each area in order to obtain total perfusion of the encephalus. The perfusion must always be quantitatively modulated as a function of the location of the largest masses.

For example, if there is one mass in the right frontal area, it is appropriate to deliver 250 cm3 of solution in that anatomic compartment while the remaining 250 cm3 are subdivided in the other two vascular areas.
The patient is conscious during the infusion, and he is actually the person who dictates rhythm and speed, because the slightest vascular effect is sensed immediately.

The therapeutic scheme is based on the dimensions of the masses – the larger they are, the more they need additional cycles delivered arterially.
The dimensional limit of 3-3.5 cm within which a rapid shrinking of the masses is possible turns out to be a determining factor.

Instead, when masses greater than 4-5 cm have to be treated – or in the presence of multiple locations in all hemispheres – it is necessary to increase the amount and frequency of the cycles of therapy.

An ever-present side effect during the therapy is thirst. A general but momentary sense of pain as well as tachycardiac events are the most common symptoms.

In cases where the masses are very large or in the presence of a diffused meningeal carcinosis, a loss of mental performance may be observed after the first treatment sessions which, although sometimes acute and may persist for several hours, completely disappears after the treatment.

• More information about the book “Cancer is a Fungus” by Dr Tullio Simoncini [new window]